Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;13(2):169-81.
doi: 10.1586/14787210.2015.999667.

Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis

Stacey A Hurst  1 , Kristie E Appelgren, Athena P Kourtis
Affiliations
Review

Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis

Stacey A Hurst et al. Expert Rev Anti Infect Ther. 2015 Feb.

Abstract

The prevention of mother-to-child transmission (PMTCT) of HIV is one of the great public health successes of the past 20 years. Much concerted research efforts and dedicated work have led to the achievement of very low rates of PMTCT of HIV in settings that can implement optimal prophylaxis. Though several implementation challenges remain, global elimination of pediatric HIV infection seems now more than ever to be an attainable goal. Often overlooked, the role of prophylaxis of the newborn is nevertheless a very important component of PMTCT. In this paper, we focus on the role of neonatal and infant prophylaxis, discuss mechanisms of protection, and present the clinical trial-generated evidence that led to the current recommendations for preventing infections in breastfed and non-breastfed infants. PMTCT of HIV should not end at birth; a continuum of care extending postpartum and postnatally is required to minimize the risk of new pediatric HIV infections.

Keywords: HIV; breastfeeding; infant; mother; neonatal; perinatal; prevention; prophylaxis; transmission.

PubMed Disclaimer

References

    1. Kourtis AP, Bulterys M. Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways. Clin. Perinatol. 2010;37(4):721–737. vii. - PubMed
    1. Mandelbrot L, Burgard M, Teglas JP, et al. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS. 1999;13(15):2143–2149. - PubMed
    1. Zack JA, Haislip AM, Krogstad P, Chen IS. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Vir. 1992;66(3):1717–1725. - PMC - PubMed
    1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med. 1994;331(18):1173–1180. [Seminal study that transformed the field of HIV prevention and the first example of use of ARV as pre- exposure prophylaxis for infants.] - PubMed
    1. Centers for Disease Control (CDC) Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43(RR-11):1–20. - PubMed

Substances

LinkOut - more resources